← All organizations
University of Versailles
Academic/HospitalWebsite ↗
Also known as: AP--HP and University of Versailles SQY | AP-HP and University of Versailles SQY | Central Hospital of Versailles | Central Hospital, Versailles | CH Versailles | Foch Hospital | Hôpital Foch | HOPITAL de FOCH | Hopital Foch | Hopital Foch, 92150 Suresnes, France | Hopital Foch 92151 Suresnes | HOSPITAL, FOCH | University of Versailles | Versailles Hospital
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1991Last known activity
Jun 30, 2025
Timeline
1990s
- Jan 1, 1991
University of Versailles— Founded
Drugs by trial phase (79 distinct, 74 trials)
Phase 4 (21 own, 0 via acquisition)
Phase 3 (27 own, 0 via acquisition)
Phase 2 (26 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Studied for
- Acute Lung Injury
- Adenomyosis
- Aortic Dissection
- Blast Crisis
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Transitional Cell
- Colorectal Neoplasms
- Contracture
- Critical Illness
- Endometriosis
- Hemorrhage
- Hypotension
- Infertility
- Infertility, Female
- Influenza, Human
- Kidney Neoplasms
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid, Chronic-Phase
- Lung Diseases, Obstructive
- Lung Neoplasms
- Multiple Myeloma
- Myotonic Dystrophy
- Nausea
- Neoplasms, Plasma Cell
- Philadelphia Chromosome
- Pneumonia
- Pneumonia, Viral
- Postoperative Nausea and Vomiting
- Postoperative Pain
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Pulmonary Disease, Chronic Obstructive
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Respiratory Insufficiency
- Sepsis
- Shock
- Shock, Septic
- Tendinopathy
- Torticollis
- Ureteral Neoplasms
- Urinary Bladder Neoplasms
- Vomiting
Recent trials (50)
- NCT06892951CollaboratorPhase 1/Phase 2Jun 30, 2025
- NCT06835491Lead sponsorPhase 3Jun 15, 2025
- NCT06835491Sponsor investigatorPhase 3Jun 15, 2025
- NCT06757244Lead sponsorPhase 2Jan 15, 2025
- NCT06294847Lead sponsorPhase 3Jul 31, 2024
- NCT05329090Lead sponsorPhase 3Mar 11, 2022
- NCT04945148Overall official - principal investigatorPhase 2Dec 31, 2021
- NCT04945148Lead sponsorPhase 2Dec 31, 2021
- NCT04617756CollaboratorPhase 2Jun 1, 2020
- NCT04384731Sponsor investigatorPhase 2May 27, 2020
- NCT04403269Lead sponsorPhase 2May 5, 2020
- NCT04403269Reponsible party - principal investigatorPhase 2May 5, 2020
- NCT04357613Reponsible party - principal investigatorPhase 2May 1, 2020
- NCT04357613Overall official - principal investigatorPhase 2May 1, 2020
- NCT04357613Lead sponsorPhase 2May 1, 2020
Details
- Founded
- Paris, FR Jan 1, 1991
- Last known activity
- Jun 30, 2025